Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
The model's full reasoning — Q4 2017 call → NOWe need to determine if there is a clear gap between the trailing period being reported and the level at which the business is already operating right now, as described by management. The call is for Q4 2017 and full year 2017. Management discusses many initiatives, partnerships, and ongoing activities. We need to see if they convey that the current business is already busier than the reported period, and that management treats the reported numbers as behind the business. Key points from the call: - Dave Stack talks about the opioid epidemic and EXPAREL's position. - They mention partnerships with J&J, Cancer Treatment Centers, ISQIC, WellStar, University of Tennessee. - They discuss clinical programs: nerve block sNDA, pediatric plan, Phase 4 studies (C-section, hip fracture, spine, colorectal, breast reconstruction) - some are enrolling, some to begin later. - They mention DepoMeloxicam IND submitted, DepoTranexamic Acid discontinued. - They discuss CMS reimbursement efforts, J code application. - J&J partnership: account activation, PEAK programs, educational programs, digital video campaigns. They say "J&J has committed to resourcing a six-fold increase in the number of PEAK programs in 2018." They mention AAOS upcoming. - Financial results: Q4 sales $78.7M, full year $282.9M, guidance for 2018 $300-310M. - Charlie Reinhart says guidance is conservative, and they expect to update as they gain visibility. Now, does management convey that the present is already busier than the print? They talk about many ongoing initiatives, but are these already generating revenue or activity that is not reflected in the reported period? The reported period is Q4 and full year 2017. The call is in February 2018. They discuss things like J&J partnership that started in 2017, but they say it's gaining traction. They mention "accelerate EXPAREL daily growth to 10% for the fourth quarter of 2017." So the growth is already in the numbers. They talk about new partnerships formed recently (WellStar, CTCA, UT) but these are educational/awareness, not necessarily immediate revenue. They talk about Phase 4 studies that are enrolling or to begin later. They talk about CMS efforts that are ongoing. Management's posture: They are guiding 2018 sales of $300-310M, which is about 6-10% growth from 2017. They say the guidance is conservative and they expect to update.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
BFI · Q3 2021 → YESThe question is whether there's a clear gap between the trailing period being reported (Q3 2021) and the current operating level, as told by management. YES The transcript shows management treating the Q3 results as trailing behind the combined company's current scale. Ian Baines opens by noting the November 3 acquisition closed just days before the call, immediately framing the business as now operating under the combined structure with 61 new locations. Julio Ramirez and Mike Rabinovitch repeatedly reference 2021 developments that occurred after September 30—10 new restaurant openings including one in October, 15 additional Ghost Kitchens, 32 signed leases, and the acquisition itself—as already-real activity driving the current state.
ADSE · Q4 2021 → YESThe question is: Is there a clear gap between the trailing period being reported and the level at which the business is already operating right now, such that management describes a company that has a...YES The transcript shows a clear gap. Management repeatedly frames the company as already operating at a higher level than the 2021 print: a €60 million+ order backlog (explicitly “year-to-date” and “just completed Q1”), U.S. business launched in late 2021 with “initial success … world orders received,” a signed ChargePost contract for 50 units with plans for >10,000 more, U.S. manufacturing plant search already underway with opening expected this year, service contracts expected to start in 2022, and new hires completed.
BFIN · Q1 2022 → YESThe question is whether there's a clear gap between the trailing period being reported (Q1 2022) and the current operating level, as described by management. YES The transcript shows management explicitly updating on April activity as already real and substantial, with loan growth hitting $45 million in April alone (pushing the portfolio over $1.1 billion), Equipment Finance originating more in April than the entire Q1, and overall originations at $148 million in April.